LOBEF (Lobe Sciences) Accounts Payable: $1.81 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LOBEF Lobe Sciences Ltd LOBEF
16 GF Score
Price $0.08
! 2 Warning Signs
View Full Analysis

What is Lobe Sciences Accounts Payable?

Lobe Sciences LOBEF -2.44% 16 Accounts Payable is $1.81 Mil as of Feb. 2026. GuruFocus rates LOBEF with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Lobe Sciences's Accounts Payable for the quarter that ended in Feb. 2026 was $1.81 Mil.

Lobe Sciences's quarterly Accounts Payable increased from Aug. 2025 ($1.44 Mil) to Nov. 2025 ($1.89 Mil) but then declined from Nov. 2025 ($1.89 Mil) to Feb. 2026 ($1.81 Mil).

Lobe Sciences's annual Accounts Payable declined from Aug. 2023 ($1.43 Mil) to Aug. 2024 ($0.57 Mil) but then increased from Aug. 2024 ($0.57 Mil) to Aug. 2025 ($1.44 Mil).

Lobe Sciences Accounts Payable Related Terms

Lobe Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Lobe Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lobe Sciences Accounts Payable Chart

Lobe Sciences Annual Data
Trend Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.01 1.43 0.57 1.44

Lobe Sciences Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 1.01 1.44 1.89 1.81
LOBEF
16GF Score
Lobe Sciences Ltd LOBEF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lobe Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.81 Mil mean?
Lobe Sciences (LOBEF) has a Accounts Payable of $1.81 Mil as of Feb. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lobe Sciences and its competitors.
Is Lobe Sciences' Accounts Payable too high?
Lobe Sciences' current Accounts Payable is $1.81 Mil. Overall, Lobe Sciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Lobe Sciences' Accounts Payable compare to VRTX and REGN?
Lobe Sciences' Accounts Payable of $1.81 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lobe Sciences and its competitors. Lobe Sciences's current Accounts Payable is $1.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lobe Sciences stock overvalued right now?
Lobe Sciences (LOBEF) has a current Accounts Payable of $1.81 Mil. The current Accounts Payable is $1.81 Mil. Lobe Sciences' overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Lobe Sciences (LOBEF), the current Accounts Payable is $1.81 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lobe Sciences Business Description

Other Exchanges LOBE:GermanyLOBE:Canada
Address 1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company focused on using lipid technology that develop therapies for orphan and rare diseases. It commercializes Altemia MF, a medical food intended to address nutritional deficiencies associated with sickle cell disease. Through its subsidiaries, the company also holds a majority interest in the development of Conjugated Psilocin for potential use in neurological and psychiatric indications. The company operates in one reportable segment, being the biopharmaceutical development of new medicines.
16GF Score

Get the complete analysis for LOBEF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price